This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-17 May 2023 and includes updates on Legionnaires’ disease, avian or animal influenza (H5), MDR S.Typhi, Marburg virus disease and antifungal-resistant Trichophyton indotineae.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 May 2023 and includes updates on measles, COVID-19, influenza and swine influenza, group A Streptococcal infection, Marburg virus disease, Lassa fever, diphtheria and mpox.
EU/EEA countries are reporting an increased number of Escherichia coli (E. coli) isolates carrying the blaNDM-5 gene that makes them resistant to carbapenems, antibiotics.
Analysis of whole genome sequencing and epidemiological data of 874 E. coli isolates from the national collections of 13 countries confirmed the increase of E. coli isolates carrying blaNDM-5 which was previously detected in the CCRE survey.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 April - 6 May 2023 and includes updates on COVID-19, influenza, echovirus, Marburg virus, mpox, MERS, and the seizure of a reference laboratory in Sudan.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 April 2023 and includes updates on cholera, avian influenza, COVID-19, invasive meningococcal disease, influenza, Marburg virus disease, and the seizure of a reference laboratory by an armed group.